Boehringer Ingelheim Venture is a the corporate venture arm of Boehringer Ingelheim, a pharmaceutical company based across the globe. The firm makes early stage investments worldwide and channels its investments into innovative pharmaceutical and medical technologies companies, with a focus that includes next generation vaccines and NBEs, and regenerative medicine.
Venture Capital
1 funds found in our dataset.
Built for investment teams that need to move faster.
Intelligently process data room financials, generate auditable analyses, and export IC-ready deliverables.